Prolet

Quick links to important sections

Prolet

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prolet

What is Prolet? (Carprofen)

This foundational section defines the pharmaceutical identity, composition, and general purpose of Prolet, an NSAID formulated for veterinary use.

Property Description
Active ingredient Carprofen
Form Tablets (Oral), Injectable Solution (Parenteral)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Pain, Inflammation, and Fever Reduction
Origin Synthetic (Propionic Acid Derivative)

What Type of Medicine is Prolet?

Prolet is the non-proprietary designation for a pharmaceutical preparation whose sole active ingredient is Carprofen, a substance classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification places it within the broader group of propionic acid derivatives, synthetic compounds that reduce inflammation, pain, and fever systemically. The compound's profile is often clinically recognized for its selective action in canine patients, which sets it apart from many older, less targeted NSAIDs.

The substance is produced synthetically and is intended exclusively for use in veterinary medicine, specifically addressing the needs of the canine patient group. Carprofen primarily provides relief by targeting symptoms of inflammation in the body.


Understanding the Prolet Composition and Forms

The core composition of this product consists of the active ingredient Carprofen combined with necessary pharmaceutical excipients to form a stable drug preparation. These excipients facilitate the stability and proper delivery of the active substance within the final product. Prolet is made available in several distinct dosage forms to accommodate different clinical needs and route of administration requirements.

These forms include palatable tablets (chewable and caplet), designed for oral ingestion, which promotes easy compliance, and a sterile injectable solution, which is administered via the parenteral route by a healthcare professional. This variety of presentation is designed for therapeutic flexibility.


What is the General Purpose of Prolet?

The general purpose of Prolet is to provide comprehensive support by modulating the body's responses to pain and swelling. Its function is to deliver simultaneous anti-inflammatory, analgesic (pain relief), and antipyretic (fever-reducing) effects. For instance, the drug is typically used to manage discomfort stemming from conditions like stiffness or general mobility issues. Carprofen is used for managing pain and stiffness. This three-pronged action is achieved by interrupting the chemical signals that drive the inflammatory process. The benefit of this systemic action is the reduction of discomfort and associated swelling, supporting the restoration of mobility and general comfort.

Regulatory References

  1. Carprofen - DailyMed (NIH)

What side effects are possible with Prolet?

Possible Side Effects and Safety Information

The officially documented safety profile of Prolet (Carprofen) is primarily characterized by adverse reactions affecting specific organ systems and clear safety restrictions defined in regulatory labels.


Adverse Reaction Scope

Adverse reactions are classified based on regulatory frequency standards:

  • Common Adverse Reactions: The most frequently reported effects are Gastrointestinal Disorders, including vomiting, diarrhea, anorexia (loss of appetite), and general systemic effects such as lethargy.
  • Uncommon/Rare Adverse Reactions: Less frequent effects include changes in the Hepatic System (e.g., enzyme elevation, jaundice), severe Renal System effects (e.g., acute renal failure), and Hypersensitivity reactions.

Serious Safety Concerns

Regulatory documents explicitly list serious adverse reactions that, while not common, are clinically significant:

  • Gastrointestinal Complications: These include ulceration, perforation, and hemorrhage.
  • Systemic Toxicity: Potential for severe, sometimes fatal, drug-induced hepatotoxicity and acute renal failure are documented.

Safety Considerations and Restrictions

Safety limitations in official labeling apply to specific contexts and populations:

  • Specific Populations: Use is not recommended in individuals with severe pre-existing cardiac, renal, or hepatic disease. Furthermore, the drug should be avoided in patients who are dehydrated, hypotensive, or hypovolemic (low blood volume), as this increases the risk of renal adverse effects.
  • Time-Related Patterns: Adverse reactions are officially noted to occur more frequently early in the course of treatment or during periods of dose escalation.

The regulatory safety profile is entirely descriptive, documenting the nature and frequency of possible adverse effects without providing clinical advice or treatment instructions.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented manifestations of Prolet (Carprofen) overdose and the immediate actions mandated by government regulatory authorities.


Documented Overdose Manifestations and Severe Outcomes

Overdose or intolerance often presents with signs primarily affecting the gastrointestinal system. The regulatory labeling specifies signs and potential severe outcomes:

Manifestations Severe Outcomes
Vomiting, Diarrhea, Decreased appetite Acute Renal Failure
Melena (black, tarry stools), Hematemesis Acute Hepatic Toxicity
Lethargy, Incoordination Gastrointestinal Ulceration/Bleeding

Serious outcomes, including acute renal failure and acute hepatic toxicity, are officially documented risks associated with toxic exposure, particularly in patients with pre-existing organ dysfunction or dehydration.


Official Emergency Actions Required

Immediate professional attention is required upon observing signs of intolerance or suspected overdose:

  • Discontinue Therapy: The medication must be stopped immediately.
  • Contact Professional: The caregiver must contact a veterinarian immediately for the patient. In the event of accidental human consumption, a physician must be called immediately.

There is no specific antidote listed in the official prescribing information. Management is supportive and symptomatic, focusing on organ protection and decontamination.

Note on Risk: The label specifically warns that Carprofen is for dogs only; cats should not be given Prolet due to high toxicity risk.

Therapeutic Uses of Prolet

Prolet is commonly used in clinical settings that involve acute or unstable symptom patterns related to symptoms related to physical discomfort. Its core therapeutic use is for managing pain and inflammation. The medication is relevant across domains where additional symptomatic support is needed, including osteoarthritis, degenerative joint disease, and pain following post-surgical procedures or soft-tissue injuries.

The therapeutic approach is relevant for easing challenging manifestations. This therapeutic benefit is aligned with supportive relief when symptoms interfere with routine activities.


Easing Discomfort and Supporting Mobility

Prolet helps address symptom clusters that may become intense or disruptive, such as chronic stiffness and lameness associated with joint degradation, or acute pain and swelling following trauma. By offering symptomatic relief and helping manage inflammation, the medication contributes to improved comfort and assists with maintaining functional stability, thereby easing the overall symptom load of persistent or acute manifestations. It is relevant when supportive symptom management is appropriate, applied during phases where symptoms become more noticeable.


Quick Fact: Relief for Stiffness and Pain

Regulatory References

  1. NIH DailyMed official label overview

Eligibility and Restrictions for Use

Who can and cannot use Prolet?

Eligibility scope Official Regulatory Status
Allowed Species Dogs (Canine patient group) only.
Contraindicated Groups Cats; animals with known hypersensitivity to carprofen or other NSAIDs; dogs with existing gastrointestinal ulceration or bleeding.
Restricted Use Conditions Severe pre-existing hepatic, renal, or cardiac disease; certain bleeding disorders; use must be avoided in dehydrated or hypotensive animals.
Age Limitations Very young dogs (under 6 weeks/4 months) are restricted; use requires caution in aged dogs.
Pregnancy/Lactation Safe use has not been established in pregnant, lactating, or breeding dogs, and is generally contraindicated.

Eligibility classifications (high-level) Official Regulatory Status
Severity Classification Contraindicated (Absolute prohibition); Use Not Established (Safety not confirmed); Avoid Use (Conditional restriction).

Connection to the overall eligibility profile: Regulatory documents strictly define who can and cannot use Prolet by confirming the single Target Species (Dogs) and systematically listing population exclusions. These rules prohibit use in animals with hypersensitivity and severe pre-existing organ disease. Furthermore, the safe use has not been established in very young, pregnant, or breeding dogs, requiring specific caution or avoidance in these groups.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory documentation for Prolet (Carprofen) establishes specific restrictions and constraints regarding co-administration with other substances.


Formal Restrictions and Timing Requirements

The concurrent administration of Prolet with Glucocorticoids (Corticosteroids) is formally prohibited in regulatory labeling. Furthermore, a mandatory 24-hour separation period is required, meaning Prolet must not be administered concurrently or within 24 hours of other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or Glucocorticoids. Certain official documents also advise against the concurrent use of Anticoagulants due to the heightened risk of bleeding and hemorrhage.

Pharmacodynamic and Exposure Alteration

Co-administration with Other NSAIDs is generally advised against, as regulatory documents note this increases the risk of additive gastrointestinal toxicity. Similarly, use with Potentially Nephrotoxic Drugs or Diuretics carries an additive risk of renal toxicity. The efficacy of Angiotensin-Converting Enzyme (ACE) Inhibitors may be reduced when co-administered.

Pharmacokinetically, Carprofen is highly protein-bound; this creates a risk of competitive displacement with Other Highly Protein-Bound Medicines, a documented interaction that may increase the toxic effects of the co-administered drug.

Condition-Specific Cautions

Regulatory documentation notes that the risk of interaction-related renal toxicity is significantly heightened in patients who are in compromised physiological states, such as being dehydrated, hypovolaemic, or hypotensive.

Mechanism of Action

How Prolet Works: Mechanism of Action

Prolet (Carprofen) primarily functions as a selective inhibitor of the Cyclooxygenase-2 (COX-2) enzyme, a key molecular target in the Arachidonic Acid Cascade. This targeted interaction suppresses the enzyme's ability to synthesize prostaglandins ( PGE2). By limiting this core molecular step, the drug initiates a cascade that limits the biochemical cascade initiated by PGE2 production and influences the signaling dynamics within local tissue .

The reduction in PGE2 synthesis leads to two distinct physiological adjustments. Peripherally, the scarcity of prostaglandins reduces the sensitization of nociceptive nerve endings, functionally increases the activation threshold of peripheral nociceptors. Centrally, the mechanism involves interrupting the PGE2 signaling within the brain's hypothalamus, which influences the hypothalamic thermal set-point.

The drug's functional scope is confined to modulating pathways mediated by the COX enzyme system; it exerts negligible mechanistic effect on pathways independent of the COX system. Crucially, the preferred COX-2 selectivity that defines its mechanism is dose-dependent, meaning the differentiation from COX-1 decreases if the drug concentration significantly exceeds the designed therapeutic window.

Dosage and Administration Information

Administration and Dosage Principles

Prolet (Carprofen) is made available in two distinct pharmaceutical forms: oral tablets (caplets) and a sterile injectable solution for professional use. The medication can be administered by the oral route for standard use or via the parenteral route through intravenous (IV) or subcutaneous (SC) injection. The injectable solution is specifically not approved for intramuscular (IM) use.


Standard Dosage and Frequency

Administration is governed by a standard total daily dose of 4.4 mg/kg of body weight. The precise dose calculation requires accurate body weight determination prior to administration. This total amount may be administered either once daily or divided into two equal applications of 2.2 mg/kg each, administered every 12 hours. It is generally emphasized to utilize the lowest effective dose for the shortest duration necessary to achieve the desired effect.


Contextual Use and Course Duration

Oral forms may be given with or without food. For acute pain management, such as post-operative care, a single injectable dose (4.0 mg/kg) is typically administered pre-operatively. This acute parenteral therapy may be followed by oral tablet administration for a period of up to five days to provide continuous post-operative care. Prolet is also appropriate for long-term treatment plans, such as those for chronic conditions, provided appropriate monitoring is utilized. If a scheduled dose is missed, it is advised not to double the dose; the regular schedule should be resumed if the time for the next dose is near.


Population-Specific Use

Use in patients less than six weeks of age has not been established. Furthermore, careful management and potentially a reduced dosage may be required when Prolet is administered to aged patients.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prolet

Evidence for Managing Chronic Pain and Inflammation

Research exploring chronic pain outcomes related to physical discomfort in patients with osteoarthritis was conducted. Studies explored Prolet in canine patients diagnosed with naturally occurring osteoarthritis or degenerative joint disease. The evidence includes short-term randomized, controlled clinical trials (RCTs) and some observational settings exploring how symptoms change over time.

Findings describe patterns observed in these studies, which included measurements related to changes in outcomes reflecting daily functioning or activity level, such as changes in limb function and mobility. The patient-reported experiences from owners also described patterns associated with changes in comfort assessments over intermediate-term treatment periods, typically spanning up to four months. However, long-term effects are not fully established for continuous use beyond intermediate durations. Limited information for long-term outcomes remains a research limitation, and evidence quality varies across studies, particularly when relying on owner-reported experiences.

Evidence for Managing Acute Post-Surgical Pain

Prolet was evaluated in conditions associated with acute or disruptive episodes, specifically following surgical procedures (both soft tissue and orthopedic). Research examining short-term, acute outcomes was based on randomized and controlled studies. This research examined acute pain intensity and the use of supplemental pain medication.

Data were collected related to monitored pain scores on validated pain scales in the immediate post-operative period. Studies reported how symptoms evolved, and research examined the association with the frequency of additional (rescue) analgesia administration, typically within the first few days after surgery. However, follow-up durations were limited to the immediate recovery window, usually up to five days. Comparative evidence against certain other medications is also lacking or subgroup findings are uncertain due to modest sample sizes in some specific trials.

What Remains Uncertain About the Research Base

The research base has several limitations, including that follow-up durations were limited, mainly focusing on short-term or intermediate outcomes. Data for certain subgroups, such as very young or highly geriatric patients, remain insufficient in controlled studies. Furthermore, controlled data for other animal species remain insufficient, and long-term effects are not fully established through controlled, prospective studies. Research provides context but not individual predictions about whether an individual will respond similarly to the group patterns observed in the studies.

Key Studies & References

  1. Carprofen (Novox/Rimadyl/Vetprofen) Official Label Overview - DailyMed

Frequently Asked Questions (FAQ)

Common questions about Prolet (FAQ)


Q: Is Prolet a type of antibiotic?

A: According to official regulatory and scientific classification, Prolet is a type of non-steroidal anti-inflammatory drug (NSAID). Its primary function is to help manage pain and inflammation in the body. It is not classified as an antibiotic and does not treat bacterial infections.


Q: What is the main reason a doctor might prescribe Prolet?

A: Official labeling indicates that Prolet is approved for the relief of pain and inflammation associated with certain conditions. This can include managing pain following soft tissue procedures or addressing chronic conditions affecting the joints, as described in regulatory documents.


Q: How quickly does Prolet usually start to work?

A: The official product information addresses the onset of action as part of its pharmacokinetic data, which describes how the body processes the drug. However, the time it takes for an individual to notice symptom relief can vary depending on the condition being treated and personal factors.


Q: Are there any common side effects people report with Prolet?

A: Regulatory documents list potential adverse reactions. For drugs in the NSAID class, commonly reported effects often involve the gastrointestinal system, such as mild upset stomach, vomiting, or loose stools. This information is generally reported in the adverse reactions section of the official product label.


Q: Can Prolet affect my ability to drive or operate machinery?

A: Official labeling advises awareness of potential central nervous system (CNS) effects. These can include feeling dizzy, lightheaded, or sleepy, which could impact a person's ability to drive or safely operate complex machinery.


Q: Is it true that Prolet can cause drowsiness?

A: Drowsiness or lethargy is an effect that has been reported in post-marketing surveillance for drugs within this therapeutic class. This information is included among the potential adverse reactions listed in the official product information.


Q: Does Prolet interact with common over-the-counter pain relievers?

A: Official documentation states that combining Prolet alongside other non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids is generally discouraged. This is due to the potential for an increased risk of serious side effects, particularly in the stomach and intestines.


Q: What is the difference between Prolet and other similar medicines?

A: Prolet is categorized as a selective COX-2 inhibitor, which is a specific type of NSAID. Its pharmacological properties, including its chemical structure and targeted mechanism of action, are detailed in official documents to distinguish it from other pain and inflammation relievers.


Q: Will I have withdrawal symptoms if I stop taking Prolet suddenly?

A: Regulatory authorities do not classify Prolet as a controlled substance with known potential for dependence. Therefore, the official documents do not typically describe withdrawal symptoms similar to those associated with narcotic or addictive medications.


Q: What happens if I accidentally take more Prolet than prescribed?

A: The official label includes a section addressing overdose risk. Exceeding the recommended dosage may increase the risk of serious adverse effects, most notably affecting organs such as the stomach, liver, or kidneys.


Q: Is Prolet a controlled substance?

A: No. Official regulatory documents confirm that Prolet (Carprofen) is a non-narcotic pain reliever and is not listed as a controlled substance with potential for abuse under regulatory frameworks like the U.S. Controlled Substances Act.


Q: Does Prolet cause weight gain or weight loss?

A: The official adverse reaction list details numerous potential side effects. While regulatory documents report various effects, significant changes in body weight are generally not highlighted as a common or characteristic side effect of Prolet.


Q: Can I take Prolet if I have liver problems?

A: Due to how the body processes the medication, regulatory documents indicate that caution is generally necessary, and use may be contraindicated, for individuals with certain pre-existing liver diseases or when liver function is impaired.


Q: What if I have kidney problems, is Prolet still an option?

A: Regulatory warnings indicate that Prolet, like other drugs in this class, is associated with specific precautions and may be contraindicated for use in patients with known impaired renal (kidney) function. This is because the kidneys play a role in eliminating the drug from the body.


Q: Are there any known interactions between Prolet and herbal supplements?

A: Official documentation focuses on interactions with other medicines but notes that caution is generally necessary regarding supplements or herbal remedies that may also affect factors like blood clotting, kidney function, or gastrointestinal health.


Q: Can Prolet be used for conditions other than what it's mainly approved for?

A: Regulatory agencies review and approve medications for specific conditions, which are listed in the official Indications section of the label. Regulatory agencies do not approve or review the use of a medicine for conditions not listed in this official documentation.


Q: What are the serious but rare side effects of Prolet?

A: The official regulatory label contains important warnings for serious, though rare, adverse reactions. These potential risks include severe issues related to gastrointestinal ulceration or bleeding, serious skin reactions, and effects on the liver and kidneys.


Q: Does Prolet interact with birth control pills?

A: Official documents list known interactions with various medications. Although direct effects on oral contraceptives are not always specifically noted, the label advises reviewing all other concurrent medications, especially those that affect liver enzymes.


Q: How does the research evidence for Prolet compare to its claims?

A: The official drug label contains a dedicated Clinical Studies section. This section summarizes the controlled human trials and scientific data that were reviewed and accepted by the regulatory agency to support the drug's approved indications and claims.


Q: Is Prolet addictive?

A: Prolet is a non-narcotic medication and is not classified by regulatory bodies as a controlled substance with the potential for addiction or abuse.


Q: Can Prolet cause changes in mood or behavior?

A: Regulatory documents list central nervous system (CNS) and psychiatric adverse effects observed in post-marketing reports for this drug class. Changes in mood, behavior, or cognitive function have been reported as potential side effects.


Q: Is the active ingredient in Prolet available in a generic version?

A: Regulatory listings, such as the FDA Orange Book, indicate that the active ingredient, Carprofen, has approved generic versions available. The availability of generic alternatives typically begins after the original drug's patent and exclusivity periods have ended.


Q: Does taking Prolet make you feel tired or energized?

A: The adverse reactions section reports effects like tiredness (lethargy) or fatigue as possible, generally uncommon, side effects. Significant energizing effects are not typically noted in official information.


Q: What is the expected timeline for seeing the full effect of Prolet?

A: The official documents provide pharmacokinetic data on drug concentrations over time. While this data suggests how long it takes for the drug to reach steady levels in the body, the time to achieve the full therapeutic effect varies by condition and person.


Q: Can Prolet be taken during pregnancy?

A: Official regulatory documents state that the use of NSAIDs like Prolet is generally not advised during pregnancy. Specifically, use is discouraged during the third trimester due to potential risks to the developing fetus.


Q: Is it safe to breastfeed while taking Prolet?

A: Regulatory labels provide an assessment of the potential for the drug to pass into breast milk during lactation. This assessment helps determine the level of caution required when the drug is used by breastfeeding individuals.


Q: What is the shelf life of Prolet?

A: The official product label, approved by regulatory agencies, specifies the determined expiry date and shelf life. This information ensures the drug remains stable and potent when stored correctly until the specified date.


Q: Does Prolet affect blood pressure?

A: Regulatory warnings for NSAIDs indicate that they can be associated with an increase in blood pressure. These medications may also contribute to fluid retention or swelling (edema), which is noted in the official warnings.


Q: Can men and women expect different effects from Prolet?

A: Official pharmacokinetic and clinical studies reviewed by regulatory agencies do not typically show clinically significant differences in drug effects based solely on gender. However, individual factors can always influence response to any medication.


Q: What if I'm allergic to other medications, can I still take Prolet?

A: Official contraindications advise against using Prolet if a person has a known history of allergic reactions to Prolet, Carprofen, or other NSAIDs, such as aspirin. Regulatory guidance emphasizes caution with cross-sensitivity.


Q: Does Prolet need to be stored in the refrigerator?

A: The official label specifies the recommended storage conditions, which usually involve keeping the drug at controlled room temperature. It should be stored away from moisture and excessive heat, unless the label specifically directs refrigeration.


Q: Why are there warnings about Prolet and alcohol consumption?

A: Warnings about alcohol consumption are typically included because concurrent use of alcohol and NSAIDs can significantly increase the risk of gastrointestinal bleeding and other adverse effects, according to regulatory cautions.


Q: Is it possible to develop a tolerance to Prolet over time?

A: Regulatory data on pharmacodynamics and long-term clinical studies monitor the drug's effectiveness over time. While the maintenance of efficacy is reviewed for approved durations of use, tolerance is not generally cited as a core mechanism of concern for this drug class.


Q: How is Prolet eliminated from the body?

A: Regulatory pharmacokinetic data states that Prolet is primarily broken down (metabolized) by the liver. It is then eliminated from the body largely through the feces, with a smaller amount being excreted in the urine.


Q: Does Prolet interact with common cold or flu medicines?

A: Interaction warnings focus on specific drug classes. Caution is generally advised, as many over-the-counter cold and flu remedies may contain other NSAIDs or blood-thinning agents that could potentially interact with Prolet.


Q: Why do people sometimes stop taking Prolet?

A: Reasons for discontinuation are varied. The official adverse reactions section lists various potential side effects, which can lead to stopping treatment. Additionally, people may stop taking it when the medicine is no longer required for the acute or short-term condition it was prescribed for.


Q: Can Prolet cause changes to the skin?

A: Official drug labels list potential dermatologic adverse effects among the reported reactions. These can include various skin changes or signs of hypersensitivity reactions, as noted in the safety summary.


Q: Are there studies about Prolet's long-term safety?

A: The official label includes a Clinical Studies section which summarizes the controlled trials, including those of longer duration, that were reviewed by the regulatory agency to support the approved long-term use for chronic conditions.


How should Prolet be stored and disposed of?

How to Store and Dispose of Prolet

Storage Requirements

Prolet must be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F), with temporary excursions permitted. It is essential to keep the product in its original, tightly closed container to protect it from moisture and light. To prevent accidental ingestion or misuse, the medication must be stored in a locked cabinet or area, out of the reach of children and pets.

Disposal Instructions

Unused or expired Prolet should be disposed of in accordance with official federal and local regulations. The preferred method is to utilize a drug take-back program or mail-back envelope offered by pharmacies or law enforcement. If no take-back option is readily available, the medication (unless specifically on a flush list) may be mixed with an undesirable substance, placed into a sealed bag, and disposed of in the household trash. Do not flush the product down the toilet unless it is listed as an exception by the regulatory authority.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prolet found in:

A-Z Index: